Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Venous Thrombosis

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    May 2021
  1. ROBERT-EBADI H, Robin P, Hugli O, Verschuren F, et al
    Impact of the Age-Adjusted D-Dimer Cutoff to Exclude Pulmonary Embolism: A Multinational Prospective Real-Life Study (the RELAX-PE Study).
    Circulation. 2021;143:1828-1830.
    PubMed    


    April 2021
  2. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    PubMed     Abstract available


    March 2021
  3. BUKHARI S, Barakat AF, Eisele YS, Nieves R, et al
    Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
    Circulation. 2021;143:1335-1337.
    PubMed    


    February 2021

  4. Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2021;143:e249.
    PubMed    


    November 2020
  5. PACKARD CJ
    Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
    Circulation. 2020;142:e333-e334.
    PubMed    


  6. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
    Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
    Circulation. 2020;142:e335-e336.
    PubMed    


    October 2020
  7. MARSTON NA, Ruff CT, Sabatine MS
    Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e264.
    PubMed    


  8. QI Z, Sun A, Ge J
    Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e262-e263.
    PubMed    


    August 2020
  9. CUSHMAN M, Barnes GD, Creager MA, Diaz JA, et al
    Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and Haemostasis.
    Circulation. 2020;142:e85-e94.
    PubMed     Abstract available


    July 2020
  10. SPYROPOULOS AC, Weitz JI
    Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
    Circulation. 2020;142:129-132.
    PubMed    


    June 2020

  11. Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2020;141:e932.
    PubMed    


    May 2020
  12. HENKE PK, Kahn SR, Pannucci CJ, Secemksy EA, et al
    Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2020 May 7:CIR0000000000000769. doi: 10.1161/CIR.0000000000000769.
    PubMed     Abstract available


    April 2020
  13. POISSY J, Goutay J, Caplan M, Parmentier E, et al
    Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence.
    Circulation. 2020 Apr 24. doi: 10.1161/CIRCULATIONAHA.120.047430.
    PubMed    


    March 2020
  14. SCHWARTZ GG, Steg PG, Szarek M, Bittner VA, et al
    Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046524.
    PubMed     Abstract available


  15. MARSTON NA, Gurmu Y, Melloni GEM, Bonaca M, et al
    The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046397.
    PubMed     Abstract available


    January 2020
  16. GERGES C, Gerges M, Friewald R, Fesler P, et al
    Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Circulation. 2020 Jan 3. doi: 10.1161/CIRCULATIONAHA.119.041515.
    PubMed     Abstract available


    October 2019
  17. GIRI J, Sista AK, Weinberg I, Kearon C, et al
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Oct 4:CIR0000000000000707. doi: 10.1161/CIR.0000000000000707.
    PubMed     Abstract available


    December 2018
  18. ALBERTSEN IE, Piazza G, Goldhaber SZ
    Let's Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked.
    Circulation. 2018;138:2591-2593.
    PubMed    


    September 2018
  19. SOCHALA M, Porcher R, Stojkovic T, Becane HM, et al
    High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic Dystrophy.
    Circulation. 2018;138:1169-1171.
    PubMed    


    March 2018
  20. LAU BD, Streiff MB, Pronovost PJ, Haut ER, et al
    Venous Thromboembolism Quality Measures Fail to Accurately Measure Quality.
    Circulation. 2018;137:1278-1284.
    PubMed     Abstract available


    January 2018
  21. WANG Y, Tan X, Gao H, Yuan H, et al
    Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection.
    Circulation. 2018;137:259-269.
    PubMed     Abstract available


  22. CHI G, Yee MK, Amin AN, Goldhaber SZ, et al
    Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extende
    Circulation. 2018;137:91-94.
    PubMed    


    October 2017
  23. CAVALLARI I, Morrow DA, Creager MA, Olin J, et al
    Frequency, Predictors and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients with Symptomatic Atherosclerosis.
    Circulation. 2017 Oct 30. pii: CIRCULATIONAHA.117.031062.
    PubMed     Abstract available


    March 2017

  24. Correction to: Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Circulation. 2017;135:e788.
    PubMed    


    February 2017
  25. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Abstract available


    December 2016
  26. SINGH S, Houng AK, Reed GL
    Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and alpha2-Antiplasmin Inactivation.
    Circulation. 2016 Dec 27. pii: CIRCULATIONAHA.116.024421.
    PubMed     Abstract available


  27. BOUGOUIN W, Marijon E, Planquette B, Karam N, et al
    Factors Associated With Pulmonary Embolism-Related Sudden Cardiac Arrest.
    Circulation. 2016;134:2125-2127.
    PubMed    


  28. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    PubMed    


    November 2016
  29. SHIRAKAWA T, Iso H
    Response by Shirakawa and Iso to Letter Regarding Article, "Watching Television and Risk of Mortality From Pulmonary Embolism Among Japanese Men and Women: The JACC Study (Japan Collaborative Cohort)".
    Circulation. 2016;134:e501-e502.
    PubMed    


  30. DIXON DL, Carbone S, Abbate A
    Letter by Dixon et al Regarding Article, "Watching Television and Risk of Mortality From Pulmonary Embolism Among Japanese Men and Women: The JACC Study (Japan Collaborative Cohort)".
    Circulation. 2016;134:e499-e500.
    PubMed    


  31. GIBSON CM, Chi G, Halaby R, Korjian S, et al
    Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025427.
    PubMed     Abstract available


  32. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Abstract available


    September 2016
  33. LIPPI G, Franchini M
    Letter by Lippi and Franchini Regarding Article, "ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors".
    Circulation. 2016;134:e258-9.
    PubMed    


    May 2016
  34. GOLDHABER SZ
    Requiem for Liberalizing Indications for Vena Caval Filters?
    Circulation. 2016;133:1992-4.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: